◀ Back
A&G Pharmaceutical Receives 2009 Maryland Business Incubator Award
—Company recognized as “Best Graduate” for cancer diagnostic product development programs—
COLUMBIA, Md., June 19, 2009— A&G Pharmaceutical received the “Best Graduate Company” Award at the 2009 Maryland Incubator of the Year Awards on June 16, 2009. The award was presented in recognition of the company’s innovative diagnostic products in development based on a unique biological target, or biomarker, discovered by A&G researchers known as GP88/PGRN, which plays a critical role in helping the cancer to grow and proliferate.
A&G initiated operations in 2000 in the Emerging Technology Center incubator in Baltimore to develop and commercialize linked therapeutic-diagnostic products for personalized medicine based on its biomarker discoveries, with a focus on cancer. The company, which now has 22 employees, has two diagnostic tests for breast cancer in clinical trials, a linked breast cancer therapeutic in development, and additional longer-term diagnostic products in development for lung cancer and prostate cancer.
“We are very pleased that the Maryland business community has bestowed the honor of Best Graduate Company on A&G,” said Ginette Serrero, PhD, Chief Executive Officer of A&G. “We could not accept this award without acknowledging Ann Lansinger, President of the Emerging Technology Centers, who provided the critical assistance at A&G’s inception that enabled us to incubate and evolve into an established biotechnology company.“
About A&G Pharmaceutical
A&G Pharmaceutical discovers, develops, and commercializes innovative personalized medicine products that improve screening, monitoring, and targeted treatment of cancer and other human diseases. A&G’s Precision Antibody™ service division (www.precisionantibody.com) generates revenue to fund the drug development effort by providing customized antibodies to leading pharmaceutical and biotechnology companies as well as federal laboratories. A&G has raised $9 million in equity funding and is located in Columbia, MD.
About the Maryland Incubator Company of the Year Awards (www.mdincubatoraward.com)
The Maryland Incubator Company of the Year Awards recognizes the achievements of current and graduate companies of Maryland’s incubators across a diverse range of technologies and services. The awards, selected by a committee of regional industry leaders and early-stage investors, are sponsored by the Maryland Department of Business and Economic Development (DBED), the Maryland Technology Development Corporation (TEDCO), RSM McGladrey, Inc., and Saul Ewing LLP.
—Company recognized as “Best Graduate” for cancer diagnostic product development programs—
COLUMBIA, Md., June 19, 2009— A&G Pharmaceutical received the “Best Graduate Company” Award at the 2009 Maryland Incubator of the Year Awards on June 16, 2009. The award was presented in recognition of the company’s innovative diagnostic products in development based on a unique biological target, or biomarker, discovered by A&G researchers known as GP88/PGRN, which plays a critical role in helping the cancer to grow and proliferate.
A&G initiated operations in 2000 in the Emerging Technology Center incubator in Baltimore to develop and commercialize linked therapeutic-diagnostic products for personalized medicine based on its biomarker discoveries, with a focus on cancer. The company, which now has 22 employees, has two diagnostic tests for breast cancer in clinical trials, a linked breast cancer therapeutic in development, and additional longer-term diagnostic products in development for lung cancer and prostate cancer.
“We are very pleased that the Maryland business community has bestowed the honor of Best Graduate Company on A&G,” said Ginette Serrero, PhD, Chief Executive Officer of A&G. “We could not accept this award without acknowledging Ann Lansinger, President of the Emerging Technology Centers, who provided the critical assistance at A&G’s inception that enabled us to incubate and evolve into an established biotechnology company.“
About A&G Pharmaceutical
A&G Pharmaceutical discovers, develops, and commercializes innovative personalized medicine products that improve screening, monitoring, and targeted treatment of cancer and other human diseases. A&G’s Precision Antibody™ service division (www.precisionantibody.com) generates revenue to fund the drug development effort by providing customized antibodies to leading pharmaceutical and biotechnology companies as well as federal laboratories. A&G has raised $9 million in equity funding and is located in Columbia, MD.
About the Maryland Incubator Company of the Year Awards (www.mdincubatoraward.com)
The Maryland Incubator Company of the Year Awards recognizes the achievements of current and graduate companies of Maryland’s incubators across a diverse range of technologies and services. The awards, selected by a committee of regional industry leaders and early-stage investors, are sponsored by the Maryland Department of Business and Economic Development (DBED), the Maryland Technology Development Corporation (TEDCO), RSM McGladrey, Inc., and Saul Ewing LLP.
© 2009 A&G Pharmaceutical, Inc. All Rights Reserved. | Terms of Use | Privacy
